Healthcare -
Biotechnology - NASDAQ - US
$ 0.375
2.43 %
$ 15.5 M
Market Cap
-0.39
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
24.56%
EBIT
Estimate
30.55%
Net Income
Estimate
6.87%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Spruce Biosciences, Inc.
SPRB has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SPRB
EBIT FORECAST
EBIT Forecast Chart SPRB
NET INCOME FORECAST
Net Income Chart SPRB